Mergers & Acquisitions ·
Embecta Corp. filed an amendment to its Form 8-K to provide the historical audited financial statements of Owen…
EMBCEmbecta Corp.
Embecta Corp. filed an amendment to its Form 8-K to provide the historical audited financial statements of Owen Mumford Holdings Limited and pro forma condensed consolidated financial information required by SEC regulations following the closing of the acquisition on May 15, 2026. The transaction involved an upfront cash payment of £126.0 million ($166.1 million) plus up to £50.0 million ($65.9 million) in performance-based earn-outs, totaling a maximum value of £176.0 million ($232.0 million). Owen Mumford reported turnover of £68.6 million and profit before tax of £1.9 million for the fiscal year ended September 30, 2025. Embecta Corp. operates in the medical device industry, specializing in drug delivery technologies.